Owing to limitations to face-to-face learning events as a result of the COVID- 19 pandemic, Pfizer aims to support enduring online educational programs designed to enhance healthcare practitioner (HCP) knowledge and understanding of the etiology, diagnosis, treatment, and management of patients with axial spondyloarthritis and/or psoriatic arthritis in clinical practice.
V. Kann Rasmussen Foundation—Cultural Resilience and Global Leadership under the Conditions of Environmental Breakdown
The urgency of dealing with unsustainable consumption, the climate crisis, and their consequential impacts to our natural systems are the overall themes for the V. Kann Rasmussen Foundation. The complexity surrounding the impacts of climate change and scaling of our collective mitigation efforts are primary concerns. The Foundation favors projects that consider all life equally important, use a systems approach to address root causes and achieve change, take stock of and tell the truth about the scale, complexity, and urgency of dealing with environmental problems, are based on original thinking, creative ideas, and experimentation, alter power dynamics related to decision-making and influence, and have international significance and perspective, even if they are locally based. The V. Kann Rasmussen Foundation works primarily on international-level issues.
American Association for Cancer Research & The Mark Foundation for Cancer Research—”Science of the Patient” (SOP) Grants
The AACR-The Mark Foundation for Cancer Research “Science of the Patient” (SOP) Grants Program represents a joint effort to stimulate novel research aimed at understanding the influence of the biology of the host (i.e., patient) on the genesis, development, treatment, and survivorship of cancer.
Pfizer and the Crohn’s & Colitis Foundation—Addressing Health Disparities in Inflammatory Bowel Disease
The Crohn’s & Colitis Foundation (Foundation) is initiating this RFP for quality improvement and/or education interventions that aim to reduce the impact of health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). This project is a multi-year endeavor being conducted in collaboration with Pfizer Global Medical Grants (GMG).
Through this RFP it is Pfizer's intent to support educational projects that focus on improving the care of patients with AD by increasing patient and caregiver knowledge of the disease state, preventative measures, and emerging strategies for treatment of AD. Of particular interest are:
The PhRMA Foundation seeks transformative, multi-stakeholder-driven solutions to address challenges in assessing the value of medicines and health care services to improve patient outcomes and reduce inefficiency.
Research projects that will be considered for Pfizer support will advance the medical knowledge of acromegaly disease, its complications and treatment with pegvisomant.
Research projects that will be considered for Pfizer support will advance the medical knowledge of pediatric growth hormone deficiency. Projects submitted may include:
Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19.
Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19 that focus on an underrepresented minority (URM) patient group.
As part of data.org’s commitment to building the field of data science for social impact, they have launched a $10 million data.org Inclusive Growth and Recovery Challenge. The challenge will seek to elicit proposals for scalable and sustainable data science solutions from and for every part of the world.
Grant funding is to support innovative health services research that will advance the existing knowledge base in the areas of health care financing, delivery, management and/or policy.
Through this RFP, it is Pfizer’s intent to support educational programs that address knowledge gaps for health care providers with the most recent pneumococcal immunization recommendations as described in the updated recommendations of the Advisory Committee on Immunization Practices.
Pfizer & Lilly—2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning Competitive Grant Program
Through this RFP, it is Pfizer’s intent to support virtual programs for HCPs on Osteoarthritis and Chronic Pain associated with OA patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data from canceled or virtual rheumatology, pain, primary care or other associated medical conferences are of particular interest.
This is a competitive review process that will be conducted by the SARS CoV-2/COVID-19 MISP Review Committee. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below.
This is a competitive process that will be conducted by the Patient Engagement, Diversity and Health Literacy MISP this year. Decisions will be made on the basis of scientific merit and strategic fit within the AOI.
Promotes the development of new clinician scientists who have demonstrated success as both a clinician and a researcher. Allows investigators to spend dedicated time in research for a period of up to five years to develop a long and productive career in academic surgery. Supplements the salary of an orthopaedic researcher that has secured an NIH K08 or K23 award from the NIH (or equivalent mentored research funding).
Foundation for Opioid Response Efforts—Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support Services
FORE will initiate rapid response grant support for specific projects that aim to strengthen access to evidence-based OUD recovery services for vulnerable and high-risk populations during the COVID-19 national emergency.
In an effort to further address the unmet medical need in COVID-19, Gilead Medical Affairs is launching the COMMIT program. Successful projects should demonstrate clear objectives, defined timelines, a comprehensive operational plan, and propose data that has relevance to the medical community. Note: these projects will not have objectives/endpoints that overlap with studies that are known to be currently underway as of the day of the approval of the proposal, including those studies that are sponsored by either Gilead and/or third parties.
Robert Wood Johnson Foundation—Systems for Action (S4A) Call for Proposals for Supplemental COVID-19 Studies
Eligible teams must have an active or recently completed research study (within 12 months of application submission) that can be extended through the use of supplemental research funding.